Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial
Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial have?
Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial published?
Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial has 2013 year in the ScholarIQ index.
What is the open-access status of Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial?
Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial has bronze oa status in the ScholarIQ index.
What is the DOI of Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial?
The DOI for Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial is on the source record.
What is the OpenAlex record for Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial?
The OpenAlex for Effects of 1 year combined flavan-3-ol and isoflavone intake, on biomarkers of vascular health in statin treated postmenopausal women with type 2 diabetes: a double-blind randomised controlled trial is on the source record.